Is Elon's Empire Crumbling?

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate

Vandana Singh
February 14, 2025

On Friday, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) announced that data from its US and UK first-in-human dose escalation clinical study of CRB-701 (SYS6002) were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium.

The Phase 1 Western dose escalation study enrolled participants with metastatic urothelial cancer (mUC) and other solid tumors associated with Nectin-4 expression. These included several tumor types not previously explored in China. 

A December 2024 data cut (n=38) is being presented, of whom 26 participants were evaluable for efficacy.

The Western study enrolled participants in the top four dose cohorts used in China (1.8, 2.7, 3.6, and 4.5 mg/kg) and adopted the same Q3W regimen. 

Safety

  • No dose-limiting toxicities were encountered during the dose escalation phase of both studies.
  • CRB-701 was well tolerated, with most treatment-emergent adverse events being grade 1 or 2 in both studies.
    • Notably, few cases of peripheral neuropathy or skin rash have been reported to date in either study:Peripheral neuropathy: Western study (Grade 1-2: 5% (n=2/38), (Grade 3 or above: zero) was comparable to China study (Grade 1: 3% (n=1/37), Grade 2 or above: zero).
    • The combined peripheral neuropathy rate for both studies was 4% (n=3/75). 
    • Skin and subcutaneous disorders: 24% (n=9/38) in the Western study compared to 8% (n=3/37) in the China study. The combined rate for both studies was 16% (12/75) across all dose groups.
  • Implementation of a proactive, preventative ocular toxicity protocol in the Western study yielded a lower incidence of ocular adverse events in the 2.7 mg/kg and 3.6 mg/kg (doses selected for optimization) in the Western study (38%) compared to the China study (66%).

The PK profile seen in the Western study was comparable to that generated in the China study. CRB-701 demonstrated a longer ADC half-life and lower free-MMAE exposure relative to enfortumab vedotin (EV).

Responses were observed in several tumor types, including previously unexplored HNSCC tumors.

The dose optimization phase of the Phase 1 Western study has commenced. Participants in HNSCC, cervical, and mUC tumors are being randomized to the 2.7 mg/kg and 3.6 mg/kg cohorts.

Price Action: CRBP stock is down 8.23% at $8.70 at the last check on Friday.

Read Next:

  • Albany International To Shift Operations In Italy: What’s Next?

Continue Reading...

Popular

Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Semiconductor Stocks React To Key Policies And Earnings

Semiconductor chip companies, including Nvidia, AMD, Broadcom, Marvell Tech, and Super Micro had a volatile week due to trade policies and earnings.

Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .

President Trump's "Pure Genius" Crypto Plan - Ad

First came "Make America Great Again" (MAGA)... Then came "Make America Healthy Again" (MAHA)... Now comes President Trump's boldest initiative yet. Jeff Brown calls it "Project MAFA." It's a revolutionary crypto plan that could flood a tiny corner of the market with up to $3.7 trillion. Already, it's helping small plays jump as high as 300%, 318%, 520%, and even 600%. For a few days only, Jeff's sharing everything - including how to get a huge discount on his research.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Cathie Wood Doubles Down On Tesla Amid Elon Musk's Feud With Trump, Sells $3 Million Worth Of Coinbase Stock

On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. and Coinbase Global Inc. . These trades reflect Ark’s strategic positioning amid ongoing market developments.

Forget Nvidia: Try This Secret Instead - Ad

Wall Street icon Larry Benedict has discovered a unique way to crush Nvidia. All you have to do is change one letter in Nvidia's ticker symbol, and you could get two- or three-times bigger gains. Same thing with Tesla... Apple... and more. Sounds impossible, but it's true.

Inside the high-stakes battle to win a New York City casino license

NEW YORK (AP) — A Caesars Palace casino in the heart of Times Square. A sprawling gambling hall along Coney Island’s iconic boardwalk. A Hard Rock casino complex next to the home stadium of baseball’s New York Mets.

ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?

Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Trump Hit With Backlash Over Use of Antisemitic Slur at Iowa Rally

President Trump faced criticism from Jewish leaders and lawmakers on Friday after using a term historically associated with antisemitic stereotypes.

Elon Musk Changed His Number, Became Unreachable After Trump Feud, Reveals Speaker Mike Johnson: 'I Sent Him A Long Text Message, And Then...'

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk has reportedly changed his phone number following a fued with President Donald Trump and disagreement with Speaker Mike Johnson over the Republican's tax-and-spending bill.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Do as I say, not as I do: On my failings as an investor

If a knowledgeable observer trained his or her sights on my choices, what are the trouble spots they would identify? Here are some of the biggies.

Indigenous Wampis are ambushed in Peru after government backs out of anti-mining joint patrol

BOGOTA, Colombia (AP) — An attack by armed assailants on a patrol of a mission by the guards last week in the Peruvian Amazon has again brought into focus the issue of .

Major Rollout of Social Security X? - Ad

Before leaving D.C., Elon Musk may have greenlit "Social Security X"-a digital overhaul backed by Trump. Set to launch as soon as July 23, this shift could impact 72M Americans-and send 3 tiny tech stocks soaring.

Republican senators caution Trump against firing Fed chair Jerome Powell

WASHINGTON (AP) — is gaining some key backing on Capitol Hill from GOP senators who fear the repercussions if President follows through with the politically independent central banker.

Tariff-Driven Cash Payouts, Right Off Your Smart Phone? - Ad

The U.S. Treasury has raked in $15B from Trump's tariffs - and now, thanks to Title 15, you could pocket $100-$1,000 upfront payouts yourself. No stocks needed. Just use your phone and my #1 income strategy to start collecting now.

ASML Rises 1.1% After Key Trading Signal

A significant trading signal occurred for ASML Holding stock as it demonstrated a power inflow at $817.45, after which ASML rose up to 1.1%.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Families, kids most at risk of losing HUD housing with Trump’s proposed time limits

WOODINVILLE, Wash. (AP) — More than 1 million low-income households — most of them working families with children — who depend on the nation’s public housing and Section 8 voucher programs could be at risk of losing their under the Trump administration’s proposal to impose a two-year time limit on rental assistance.

Tesla debuts in India with upscale showroom launch in Mumbai

NEW DELHI (AP) — opened its first showroom in on Tuesday, marking the electric vehicle maker’s long-anticipated debut in the world’s third-biggest automotive market.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Seven & i Crashes 9% After Couche-Tard Yanks $47 Billion Takeover Bid, Slams 'Lack of Good Faith' Talks — Tokyo Retail Giant Calls Move 'Unilateral'

Seven & i Holdings shares tumbled 9% on Thursday on the Tokyo exchange to a low of 2,000 Japanese Yen ($13.50) after Canada's Alimentation Couche-Tard withdrew its $47 billion takeover bid, citing "persistent lack of good faith engagement." Trading resumed at 10:16 a.m. local time following a halt.

PHOTO ESSAY: In rural Alaska, collecting driftwood saves time, money and brings jobs

GALENA, Alaska (AP) — As ice breaks on the Yukon River, Jake Pogrebinsky looks at the water from shore, searching for a large log floating downstream.

President Trump's "Pure Genius" Crypto Plan - Ad

First came "Make America Great Again" (MAGA)... Then came "Make America Healthy Again" (MAHA)... Now comes President Trump's boldest initiative yet. Jeff Brown calls it "Project MAFA." It's a revolutionary crypto plan that could flood a tiny corner of the market with up to $3.7 trillion. Already, it's helping small plays jump as high as 300%, 318%, 520%, and even 600%. For a few days only, Jeff's sharing everything - including how to get a huge discount on his research.

Tim Cook's New Job Is Keeping Trump 'Happy,' Says Economist Justin Wolfers: 'Innovation Takes A Back Seat To Political Favoritism'

According to University of Michigan economist Justin Wolfers, in recent months, Apple Inc. (NASDAQ: AAPL) CEO Tim Cook has been spending far more time managing politics than pursuing new innovations.

BitMine Stock Is Trading Higher Wednesday: What's Going On?

BitMine Immersion Technologies, Inc. (AMEX:BMNR) shares are trading higher Wednesday after a Schedule 13G filing revealed that FF Consumer Growth, a firm linked to billionaire investor Peter Thiel, has taken a stake in the company.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Once Powerless, Now Priceless: V.J. Edgecombe's Journey From No Electricity to $50.4M NBA Future

Valdez "V.J." Edgecombe Jr., a young basketball player who once lived without electricity for seven years, is now on the verge of signing a contract worth $50.4 million.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service